Acquisition highlights of Vyome Therapeutics and a snapshot of its key metrics.

Founded in 2017, Vyome Therapeutics operates in the biomedical sector, concentrating on the development of targeted therapeutics for dermatological conditions. Originally focused on addressing unmet needs in the dermatology space with innovative solutions, Vyome has since broadened its approach to include extensive research and insights into microbial resistance. A notable milestone came when Vyome announced a strategic partnership with a US-based biotech firm to advance its lead product for acne treatment. Additionally, the company has diversified its portfolio by extending its research into novel drug delivery systems, thus enhancing its therapeutic impact. Competing with companies such as Ahammune Biosciences and Invictus Oncology.

Shiladitya Sengupta

Venkateswarlu Nelabhotla

Founded in 2017, Vyome Therapeutics has raised 48.30 Mn+ in funding from a total number of 8 investors.

Vyome Therapeutics – Total Funding, Funding Over Time, Funding By Rounds and More.

Funding highlights of Vyome Therapeutics and a snapshot of its key metrics.

Sabre Partners

Kalaari Capital

Aarin Capital

Iron Pillar

Romulus Capital

Perceptive Advisors

Navam Capital

Indo-US Venture Partners

Investment highlights of Vyome Therapeutics and a snapshot of its key metrics.

Vyome Therapeutics - A Health Tech Funded Company Based Out Of Princeton

Vyome Therapeutics

A snapshot of highlights, scale, and metrics

A Health Tech Funded Company Based Out Of Princeton

Vyome Therapeutics - Financials, Revenue, P&L Statement, Balance Sheet, Cash Flow & More